India’s biopharmaceutical sector is growing rapidly, driven by increasing demand for affordable healthcare solutions, vaccines, and biologics. However, developing complex biopharma products requires strong research capabilities, advanced infrastructure, and sustained funding support.
To strengthen this ecosystem, the Government of India has introduced the Biopharma SHAKTI scheme. This initiative focuses on boosting domestic innovation, improving manufacturing capabilities, and enhancing India’s global competitiveness in biologics and biosimilars.
What is the Biopharma SHAKTI scheme?
The Biopharma SHAKTI scheme is a government initiative aimed at strengthening India’s biopharmaceutical ecosystem by supporting research, development, and manufacturing of biologics and biosimilars. It focuses on enabling indigenous innovation while reducing dependence on imports.
The scheme promotes collaboration between industry, academia, and research institutions to accelerate the development of advanced biopharma products and technologies.
Key objectives of Biopharma SHAKTI initiative
- To promote innovation in biologics and biosimilars development
- To strengthen domestic research and development capabilities
- To reduce reliance on imported biopharmaceutical products
- To support affordable healthcare solutions in India
- To encourage collaboration between industry and academic institutions
- To enhance global competitiveness of Indian biopharma companies
- To accelerate commercialisation of advanced biotech innovations
Core components of the Biopharma SHAKTI scheme
- Financial support for research and development projects
- Infrastructure development for biopharma manufacturing
- Support for clinical research and product validation
- Promotion of public-private partnerships in biotechnology
- Capacity building for skilled workforce in biopharma sector
- Facilitation of technology transfer and innovation
- Strengthening regulatory and quality compliance systems
Eligibility criteria for Biopharma SHAKTI scheme
- Indian companies engaged in biopharmaceutical research or manufacturing
- Start-ups and MSMEs working in biotechnology and life sciences
- Academic and research institutions collaborating with industry
- Entities involved in biologics, biosimilars, or advanced therapies
- Applicants must demonstrate innovation and commercial potential
- Compliance with regulatory and technical standards is required
- Preference for projects with high public health impact
How to apply for Biopharma SHAKTI scheme
- Identify eligible project aligned with scheme objectives
- Prepare a detailed proposal outlining innovation and impact
- Submit application through the designated government portal or agency
- Provide technical, financial, and operational details
- Undergo evaluation by expert committees
- Participate in presentations or clarifications if required
- Receive approval and funding based on project merit
Documents required for application
- Business or institutional registration certificate
- Detailed project report or research proposal
- Financial statements and funding requirements
- KYC documents of promoters or organisation
- Collaboration agreements, if applicable
- Technical feasibility and innovation details
- Regulatory approvals or compliance documents (if required)
Conclusion
The Biopharma SHAKTI scheme is a strategic initiative aimed at strengthening India’s position in the global biopharmaceutical sector. By supporting innovation, research, and manufacturing, it helps build a robust ecosystem for biologics and biosimilars while improving healthcare accessibility.
In addition to such government support, businesses in the biotech and pharmaceutical sectors may require financial assistance for expansion and operations. In such cases, exploring options like business loans can be beneficial. It is important to evaluate the business loan interest rate before applying. Additionally, using a business loan EMI calculator can help plan repayments efficiently.
By combining policy support with effective financial planning, businesses can scale innovation and contribute to India’s growing biopharma landscape.
